Free Trial

Ardelyx (ARDX) Stock Price, News & Analysis

Ardelyx logo
$4.30 +0.11 (+2.51%)
Closing price 03:54 PM Eastern
Extended Trading
$4.30 0.00 (0.00%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ardelyx Stock (NASDAQ:ARDX)

Key Stats

Today's Range
$4.17
$4.32
50-Day Range
$3.28
$5.51
52-Week Range
$3.21
$7.18
Volume
2.84 million shs
Average Volume
4.40 million shs
Market Capitalization
$1.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.89
Consensus Rating
Buy

Company Overview

Ardelyx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

ARDX MarketRank™: 

Ardelyx scored higher than 87% of companies evaluated by MarketBeat, and ranked 134th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ardelyx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Ardelyx has only been the subject of 3 research reports in the past 90 days.

  • Read more about Ardelyx's stock forecast and price target.
  • Earnings Growth

    Earnings for Ardelyx are expected to grow in the coming year, from ($0.18) to $0.31 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ardelyx is -19.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ardelyx is -19.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ardelyx has a P/B Ratio of 5.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Ardelyx's valuation and earnings.
  • Percentage of Shares Shorted

    11.98% of the float of Ardelyx has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardelyx has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Ardelyx has recently decreased by 6.09%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ardelyx does not currently pay a dividend.

  • Dividend Growth

    Ardelyx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.98% of the float of Ardelyx has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardelyx has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Ardelyx has recently decreased by 6.09%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Ardelyx has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Ardelyx this week, compared to 10 articles on an average week.
  • Search Interest

    12 people have searched for ARDX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Ardelyx to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ardelyx insiders have bought 379.95% more of their company's stock than they have sold. Specifically, they have bought $3,402,411.00 in company stock and sold $708,914.00 in company stock.

  • Percentage Held by Insiders

    Only 4.80% of the stock of Ardelyx is held by insiders.

  • Percentage Held by Institutions

    58.92% of the stock of Ardelyx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Ardelyx's insider trading history.
Receive ARDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardelyx and its competitors with MarketBeat's FREE daily newsletter.

ARDX Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
Ardelyx Secures $50 Million Loan Amendment
Brokerages Set Ardelyx, Inc. (NASDAQ:ARDX) PT at $10.89
See More Headlines

ARDX Stock Analysis - Frequently Asked Questions

Ardelyx's stock was trading at $5.07 at the start of the year. Since then, ARDX stock has decreased by 15.3% and is now trading at $4.2950.

Ardelyx, Inc. (NASDAQ:ARDX) posted its quarterly earnings data on Thursday, May, 1st. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.07. The company's revenue for the quarter was up 61.1% on a year-over-year basis.
Read the conference call transcript
.

Shares of ARDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardelyx investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), e.l.f. Beauty (ELF), GE Aerospace (GE), Builders FirstSource (BLDR) and ServiceNow (NOW).

Company Calendar

Last Earnings
5/01/2025
Today
7/03/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ARDX
Employees
90
Year Founded
2007

Price Target and Rating

Average Stock Price Target
$10.89
High Stock Price Target
$15.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+154.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.14 million
Pretax Margin
-14.59%

Debt

Sales & Book Value

Annual Sales
$333.61 million
Price / Cash Flow
N/A
Book Value
$0.73 per share
Price / Book
5.86

Miscellaneous

Free Float
227,771,000
Market Cap
$1.02 billion
Optionable
Optionable
Beta
0.60

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:ARDX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners